Filing Details
- Accession Number:
- 0001628280-22-023396
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-22 11:52:53
- Reporting Period:
- 2022-08-22
- Accepted Time:
- 2022-08-22 11:52:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 727207 | Accelerate Diagnostics Inc | AXDX | Laboratory Analytical Instruments (3826) | 841072256 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1556290 | Steven Reichling | C/O Accelerate Diagnostics, Inc. 3950 S. Country Club Road, Suite 470 Tucson AZ 85714 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-08-22 | 5,000 | $1.39 | 67,493 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.38 to $1.40, inclusive. The reporting person undertakes to provide to Accelerate Diagnostics, Inc. (the "Issuer"), any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
Billionaire Hedge Funds
